140 related articles for article (PubMed ID: 36813059)
41. Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.
Dubois S; Viailly PJ; Bohers E; Bertrand P; Ruminy P; Marchand V; Maingonnat C; Mareschal S; Picquenot JM; Penther D; Jais JP; Tesson B; Peyrouze P; Figeac M; Desmots F; Fest T; Haioun C; Lamy T; Copie-Bergman C; Fabiani B; Delarue R; Peyrade F; André M; Ketterer N; Leroy K; Salles G; Molina TJ; Tilly H; Jardin F
Clin Cancer Res; 2017 May; 23(9):2232-2244. PubMed ID: 27923841
[No Abstract] [Full Text] [Related]
42. Gene polymorphisms of SOCS1 and SOCS2 and acute lymphoblastic leukemia.
Chen SS; Wu WZ; Zhang YP; Huang WJ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5564-5572. PubMed ID: 32495891
[TBL] [Abstract][Full Text] [Related]
43. Computational analysis for the determination of deleterious nsSNPs in human MTHFR gene.
Desai M; Chauhan JB
Comput Biol Chem; 2018 Jun; 74():20-30. PubMed ID: 29524840
[TBL] [Abstract][Full Text] [Related]
44. Predicting the most deleterious missense nsSNPs of the protein isoforms of the human HLA-G gene and in silico evaluation of their structural and functional consequences.
Emadi E; Akhoundi F; Kalantar SM; Emadi-Baygi M
BMC Genet; 2020 Aug; 21(1):94. PubMed ID: 32867672
[TBL] [Abstract][Full Text] [Related]
45. SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups.
Guo B; Huang Y; Duan Y; Liao C; Cen H
Cancer Med; 2022 Mar; 11(5):1281-1291. PubMed ID: 35106936
[TBL] [Abstract][Full Text] [Related]
46. Identification of SNPs in hMSH3/MSH6 interaction domain affecting the structure and function of MSH2 protein.
Singh S; Sharma S; Baranwal M
Biotechnol Appl Biochem; 2022 Dec; 69(6):2454-2465. PubMed ID: 34837403
[TBL] [Abstract][Full Text] [Related]
47. The rs61742690 (S783N) single nucleotide polymorphism is a suitable target for disrupting BCL11A-mediated foetal-to-adult globin switching.
Abdulazeez S; Sultana S; Almandil NB; Almohazey D; Bency BJ; Borgio JF
PLoS One; 2019; 14(2):e0212492. PubMed ID: 30768627
[TBL] [Abstract][Full Text] [Related]
48. A new reliable and highly specific monoclonal antibody to detect the C-terminal region of silencer of cytokine signaling 1.
Weissinger SE; Zahn M; Marienfeld R; Tessmer C; Moldenhauer G; Möller P
Eur J Haematol; 2021 Jul; 107(1):74-80. PubMed ID: 33714214
[TBL] [Abstract][Full Text] [Related]
49. Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach.
George Priya Doss C; Nagasundaram N; Chakraborty C; Chen L; Zhu H
Hum Genomics; 2013 Apr; 7(1):10. PubMed ID: 23561625
[TBL] [Abstract][Full Text] [Related]
50. Genomic Alterations and MYD88
Jiang S; Qin Y; Gui L; Liu P; Jiang H; Liu B; Yang J; Yang S; He X; Zhou S; Du X; Yi Y; Lin J; Shi Y
Target Oncol; 2020 Apr; 15(2):221-230. PubMed ID: 32239385
[TBL] [Abstract][Full Text] [Related]
51. High frequency of inactivating tetraspanin
Elfrink S; de Winde CM; van den Brand M; Berendsen M; Roemer MGM; Arnold F; Janssen L; van der Schaaf A; Jansen E; Groenen PJTA; Eijkelenboom A; Stevens W; Hess CJ; van Krieken JH; Vermaat JSP; Cleven AHG; de Groen RAL; Neviani V; de Jong D; van Deventer S; Scheijen B; van Spriel AB
Blood; 2019 Sep; 134(12):946-950. PubMed ID: 31366619
[TBL] [Abstract][Full Text] [Related]
52. Identification and structural characterization of deleterious non-synonymous single nucleotide polymorphisms in the human SKP2 gene.
Hosen SMZ; Dash R; Junaid M; Mitra S; Absar N
Comput Biol Chem; 2019 Apr; 79():127-136. PubMed ID: 30802828
[TBL] [Abstract][Full Text] [Related]
53. Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study.
Xu-Monette ZY; Wu L; Visco C; Tai YC; Tzankov A; Liu WM; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Zhao XF; Choi WW; Zhao X; van Krieken JH; Huang Q; Huh J; Ai W; Ponzoni M; Ferreri AJ; Zhou F; Kahl BS; Winter JN; Xu W; Li J; Go RS; Li Y; Piris MA; Møller MB; Miranda RN; Abruzzo LV; Medeiros LJ; Young KH
Blood; 2012 Nov; 120(19):3986-96. PubMed ID: 22955915
[TBL] [Abstract][Full Text] [Related]
54. BCL2 mutations in diffuse large B-cell lymphoma.
Schuetz JM; Johnson NA; Morin RD; Scott DW; Tan K; Ben-Nierah S; Boyle M; Slack GW; Marra MA; Connors JM; Brooks-Wilson AR; Gascoyne RD
Leukemia; 2012 Jun; 26(6):1383-90. PubMed ID: 22189900
[TBL] [Abstract][Full Text] [Related]
55. Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.
Taniguchi K; Takata K; Chuang SS; Miyata-Takata T; Sato Y; Satou A; Hashimoto Y; Tamura M; Nagakita K; Ohnishi N; Noujima-Harada M; Tabata T; Kikuti YY; Maeda Y; Nakamura N; Tanimoto M; Yoshino T
Am J Surg Pathol; 2016 Mar; 40(3):324-34. PubMed ID: 26752547
[TBL] [Abstract][Full Text] [Related]
56. Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma.
Xu-Monette ZY; Deng Q; Manyam GC; Tzankov A; Li L; Xia Y; Wang XX; Zou D; Visco C; Dybkær K; Li J; Zhang L; Liang H; Montes-Moreno S; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Wang SA; Miranda RN; Piris MA; Winter JN; Medeiros LJ; Li Y; Young KH
Clin Cancer Res; 2016 Jul; 22(14):3593-605. PubMed ID: 26927665
[TBL] [Abstract][Full Text] [Related]
57. BRCA2 Polymorphisms and Breast Cancer Susceptibility: a Multi-Tools Bioinformatics Approach.
Jan H; Khan NU; Al-Qaaneh AM; Tasleem M; Almutairi MH; Ali I
Cell Physiol Biochem; 2024 Mar; 58(2):128-143. PubMed ID: 38623065
[TBL] [Abstract][Full Text] [Related]
58. Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation.
Ali SK; Sneha P; Priyadharshini Christy J; Zayed H; George Priya Doss C
J Biomol Struct Dyn; 2017 Sep; 35(12):2714-2724. PubMed ID: 27677677
[TBL] [Abstract][Full Text] [Related]
59. Identification of functional SNPs in BARD1 gene and in silico analysis of damaging SNPs: based on data procured from dbSNP database.
Alshatwi AA; Hasan TN; Syed NA; Shafi G; Grace BL
PLoS One; 2012; 7(10):e43939. PubMed ID: 23056176
[TBL] [Abstract][Full Text] [Related]
60. Computational analysis of high-risk SNPs in human CHK2 gene responsible for hereditary breast cancer: A functional and structural impact.
Badgujar NV; Tarapara BV; Shah FD
PLoS One; 2019; 14(8):e0220711. PubMed ID: 31398194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
